21st WRIB Highlights

Full Immersion in Bioanalysis
  • Small & Large Molecules
  • Biomarkers
  • Immunogenicity
  • Gene/Cell Therapy
  • Vaccine Assays
  • Critical Reagents
  • Peptide & Oligos
  • New Modalities
  • LBA, Flow Cytometry
  • PCR, ELISpot, NGS
  • LC-MS/MS & HRMS
  • Hybrid LBA/LCMS
  • Emerging Technologies
Hear from Regulators...
  • US FDA
  • EU EMA
  • UK MHRA
  • Health Canada
  • Brazil ANVISA
  • Austria AGES
  • Belgium FAMHP
  • Italy AIFA
Learn What's New...
  • Method Dev. Challenges
  • Novel Case Studies
  • Emerging Approaches
  • Regulatory Standards
3-DAY Main Workshop
  • No Overlap Parallel Sessions
  • Flexibility to Choose Main Workshop DAYs
7 full-day Specialized Workshops
  • Spread throughout the week
  • Each with an in-depth Focus to maximize your learning process
Personalized Agenda
  • Choose your Main Workshop DAYs
  • Then Combine with Specialized Workshops of your interest
Questions to Regulators
  • Ask them directly to regulators at WRIB
  • Or Submit yours questions before WRIB if you want to be anonymous
Complete Speakers Slides
  • Distributed BEFORE meeting
Poster Awards
  • Free Registration for Next WRIB
  • Interviewed by Bioanalysis Journal
  • Appear in a speical feature report in the Bioanalysis Journal and on Bioanalysis Zone
Main Workshop DAY 2A - Wednesday April 14, 2027: 7am - 12:30pm - Discussion Topic List

"Regulators' Advice on Bioanalytical Method Validation (BMV) & Biomarkers Assay Validation (BAV)"

Session 1: Regulated Bioanalysis / BMV

ASK THE REGULATORS!

  • Have an Open Dialogue with the Regulators including US FDA, UK MHRA, Italy AIFA / EU EMA, Health Canada, Brazil ANVISA

    • Ask the Regulators any questions you have on Regulated Bioanalysis / BMV, and Hear Their Feedbacks on Submitted Studies and Inspections/Audits Outcomes

Session 2: Biomarkers, IVD/CDx and BAV

ASK THE REGULATORS!

  • Have an Open Dialogue with the Regulators including US FDA, UK MHRA, Belgium FAMHP / EU EMA

    • Ask the Regulators any questions you have on Biomarkers, IVD/CDx and BAV, and Hear Their Feedbacks on Submitted Studies and Inspections/Audits Outcomes